Domov › Rak debelega črevesa › North Carolina

Klinične študije za Rak debelega črevesa v North Carolina

20 študij za Rak debelega črevesa išče udeležence na lokacijah v North Carolina.

Mesta v North Carolina

Uradno besedilo študije (angleško)

Family Communications After Genetic Testing

Southeastern Medical Oncology Center-Clinton, Clinton
CaroMont Regional Medical Center, Gastonia
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
in še 2

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07143487

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07283939

Distance-Based Exercise to Preserve Function and Prevent Disability

Novant Health Cancer Institute - Kernersville, Kernersville
Novant Health Cancer Institute - Mount Airy, Mount Airy
Novant Health Forsyth Medical Center, Winston-Salem

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07059884

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

WakeMed Raleigh Campus ( Site 0094), Raleigh

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06997497

A Study of PHN-012 in Patients With Advanced Solid Tumors

PHN-012-001 Site, Durham

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07127874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Duke Cancer Center Cary, Cary
Duke Cancer Center - Investigational Chemotherapy Service, Durham
Duke Cancer Center, Durham
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07222800

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Messino Cancer Center, Asheville
The University of North Carolina At Chapel Hill, Chapel Hill
Oncology Specialists of Charlotte, Charlotte

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07284849

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

UNC- Chapel Hill, Chapel Hill

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT05059444

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

First Health of the Carolinas, Pinehurst

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07058012

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
Southeastern Medical Oncology Center-Jacksonville, Jacksonville

Vključevanje udeležencev

Starost 45–70 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Duke Cancer Center Cary, Cary
UNC Health Cancer Care Cary, Cary
Waverly Hematology Oncology, Cary
in še 22

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT05174169

Shield Post-Approval Study Protocol

Cary Gastroenterology Associates, Cary
University of North Carolina at Chapel Hill, Chapel Hill
University of North Carolina at Chapel Hill, Chapel Hill
in še 1

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 45–81 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06880055

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Charlotte
Xencor Investigative Site, Durham

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT05433142

Integrated Cancer Repository for Cancer Research

Cape Fear Valley Health System, Fayetteville

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, Durham

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 10. jun. 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Duke Cancer Center, Durham
Carolina BioOncology Institute, Huntersville

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT06040541

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

GSK Investigational Site, Durham

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 23. jan. 2026 · NCT05855200

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Chapel Hill
Massive Bio SYNERGY-AI site, Winston-Salem

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test

Virtual Research Group, Morrisville

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2025 · NCT06864338

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

University of North Carolina, Chapel Hill

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 27. jun. 2025 · NCT03175224

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.